Modulation of memory, reinforcement and anxiety parameters by intra-amygdala injection of cholecystokinin-fragments Boc-CCK-4 and CCK-8s. (Q48560852)

12 February 2018

title

Modulation of memory, reinforcement and anxiety parameters by intra-amygdala injection of cholecystokinin-fragments Boc-CCK-4 and CCK-8s. (English)

1 reference

12 February 2018

1 reference

Huston JP

1

1 reference

12 February 2018

Schildein S

2

1 reference

12 February 2018

Gerhardt P

3

1 reference

12 February 2018

Privou C

4

1 reference

12 February 2018

Fink H

5

1 reference

12 February 2018

Hasenöhrl RU

6

1 reference

12 February 2018

publication date

1 January 1998

1 reference

12 February 2018

number of pages

11

1 reference

inferred from page(s)

published in

Peptides

1 reference

12 February 2018

volume

19

1 reference

12 February 2018

issue

1

1 reference

12 February 2018

page(s)

27-37

1 reference

12 February 2018

Asymmetry in behavioral responses to cholecystokinin microinjected into rat nucleus accumbens and amygdala.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

The cholecystokinin hypothesis of anxiety and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Post-trial hormonal treatment effects: memory modulation or perceptual distortion?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Biological actions of cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Animal models of anxiety based on classical conditioning: the conditioned emotional response (CER) and the fear-potentiated startle effect

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

The role of the amygdala in fear and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

The role of the amygdala in emotional learning

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

The selective CCK-B agonist, BC 264, impairs socially reinforced memory in the three-panel runway test in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Heterogeneity of CCK-B receptors involved in animal models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

CCK-8 modulates D2 receptor agonist-induced hypermotility in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Cholecystokinin receptors mediate enhanced memory retention produced by feeding and gastrointestinal peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Do peptide-induced changes in feeding occur because of changes in motivation to eat?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Evidence that cholecystokinin-enhanced retention is mediated by changes in opioid activity in the amygdala

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

The memory enhancing effects of cholecystokinin octapeptide are dependent on an intact stria terminalis.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Characterization and visualization of cholecystokinin receptors in rat brain using [3H]pentagastrin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Enhanced learning produced by injection of neurokinin substance P into the region of the nucleus basalis magnocellularis: Mediation by the N-terminal sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Evidence for mnemotropic action of cholecystokinin fragments Boc-CCK-4 and CCK-8S.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Role of the amygdala and periaqueductal gray in anxiety and panic

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Behavioural effects of two cholecystokinin analogues: JMV 236 and JMV 179.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Cholecystokinin receptors and memory: a radial maze study.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

CCK in animal and human research on anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Conditioned place preference in the corral: a procedure for measuring reinforcing properties of drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Substance P enhancement of inhibitory avoidance learning: mediation by the N-terminal sequence.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Positively reinforcing effects of the neurokinin substance P in the basal forebrain: mediation by its C-terminal sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Anxiolytic-like effect of combined extracts of Zingiber officinale and Ginkgo biloba in the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Effect of the 5-HT3 receptor antagonist ondansetron on hypothalamic self-stimulation in rats and its interaction with the CCK analogue caerulein

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Effects of CCK antagonists on CCK-induced suppression of locomotor activity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Cholecystokinin tetrapeptide, proglumide and open-field behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

The relationship between reinforcement and memory: parallels in the rewarding and mnemonic effects of the neuropeptide substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Interactions of cholecystokinin, beta-endorphin, and their antagonists on passive avoidance behavior in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Cardiovascular responses elicited by stimulation of neurons in the central amygdaloid nucleus in awake but not anesthetized rats resemble conditioned emotional responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Passive avoidance deficit following intracerebroventricular administration of cholecystokinin tetrapeptide amide in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Blocking of cholecystokinin octapeptide behavioral effects by proglumide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Distribution and Chromatographic Characterisation of Gastrin and Cholecystokinin in the Rat Central Nervous System

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Neuromodulatory systems and memory storage: role of the amygdala

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Effects of anti-CCK-8 antiserum on acquisition and retrieval by mice in an appetitive task.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Enhanced inhibitory avoidance learning produced by post-trial injections of substance P into the basal forebrain.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Quantitative autoradiographic localization of cholecystokinin receptors in rat and guinea pig brain using 125I-Bolton-Hunter-CCK8.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Brain cholecystokinin tetrapeptide levels are increased in a rat model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Infusions of cholecystokinin octapeptide into the ventral tegmental area potentiate amphetamine conditioned place preferences.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

The benzodiazepine receptor inverse agonist FG 7142 induces cholecystokinin gene expression in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Neuronal cholecystokinin: one or multiple transmitters?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Effects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Opposite effects of mesencephalic microinjections of cholecystokinin octapeptide and neurotensin-(1-13) on brain stimulation reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Evidence for the sequential participation of inferior temporal cortex and amygdala in the acquisition of stimulus-reward associations

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Up-hill avoidance: A new passive-avoidance task

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Cholecystokinin produces conditioned place-aversions, not place-preferences, in food-deprived rats: evidence against involvement in satiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Localization in the amygdala of the amnestic action of diazepam on emotional memory

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Amygdaloid complex lesions differentially affect retention of tasks using appetitive and aversive reinforcement

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Effects of amygdala central nucleus lesions on blocking and unblocking.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

Amygdala central nucleus lesions disrupt increments, but not decrements, in conditioned stimulus processing.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900270-2

7 January 2021

10.1016/S0196-9781(97)00270-2

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

9437734

1 reference

12 February 2018